Xenon Pharmaceuticals (XENE) Change in Receivables: 2013-2025
Historic Change in Receivables for Xenon Pharmaceuticals (XENE) over the last 11 years, with Sep 2025 value amounting to -$283,000.
- Xenon Pharmaceuticals' Change in Receivables fell 440.96% to -$283,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$116,000, marking a year-over-year decrease of 132.13%. This contributed to the annual value of $614,000 for FY2024, which is 572.31% up from last year.
- Latest data reveals that Xenon Pharmaceuticals reported Change in Receivables of -$283,000 as of Q3 2025, which was up 96.26% from -$7.6 million recorded in Q2 2025.
- In the past 5 years, Xenon Pharmaceuticals' Change in Receivables ranged from a high of $7.2 million in Q1 2025 and a low of -$7.6 million during Q2 2025.
- Moreover, its 3-year median value for Change in Receivables was -$38,000 (2024), whereas its average is -$16,273.
- Within the past 5 years, the most significant YoY rise in Xenon Pharmaceuticals' Change in Receivables was 18,989.47% (2025), while the steepest drop was 34,454.55% (2025).
- Over the past 5 years, Xenon Pharmaceuticals' Change in Receivables (Quarterly) stood at -$481,000 in 2021, then plummeted by 214.97% to -$1.5 million in 2022, then soared by 119.41% to $294,000 in 2023, then spiked by 86.05% to $547,000 in 2024, then tumbled by 440.96% to -$283,000 in 2025.
- Its Change in Receivables stands at -$283,000 for Q3 2025, versus -$7.6 million for Q2 2025 and $7.2 million for Q1 2025.